These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3937224)

  • 1. Humoral inhibition of neutrophil chemotaxis in Crohn's disease.
    D'Amelio R; Pallone F; Le Moli S; Pontesilli O; Ricci R; Montano S; Rossi P
    Scand J Immunol; 1985 Dec; 22(6):597-602. PubMed ID: 3937224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.
    D'Amelio R; Rossi P; Le Moli S; Ricci R; Montano S; Pallone F
    Gut; 1981 Jul; 22(7):566-70. PubMed ID: 7262631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective release of C5a related chemo-attractant activity from complement in Crohn's disease.
    Elmgreen J; Berkowicz A; Sørensen H
    Gut; 1983 Jun; 24(6):525-31. PubMed ID: 6852633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.
    Richens ER; Thorp CM; Bland PW; Hall ND
    Dig Dis Sci; 1982 Feb; 27(2):129-38. PubMed ID: 7075407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.
    Elmgreen J; Both H; Binder V
    Gut; 1985 Feb; 26(2):151-7. PubMed ID: 3967833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective modulation of complement in Crohn's disease. C3b opsonization of zymosan by the alternative pathway.
    Simonsen T; Elmgreen J
    Scand J Gastroenterol; 1985 Sep; 20(7):883-6. PubMed ID: 4048839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil dysfunction in Crohn's disease.
    Segal AW; Loewi G
    Lancet; 1976 Jul; 2(7979):219-21. PubMed ID: 59239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease.
    Moráin CO; Segal AA; Walker D; Levi AJ
    Gut; 1981 Oct; 22(10):817-22. PubMed ID: 7028577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in alternative complement pathway mediated C3 conversion following burn injury.
    Bjornson AB; Bjornson HS; Altemeier WA
    Ann Surg; 1981 Aug; 194(2):224-31. PubMed ID: 7259350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a.
    Elmgreen J
    Gut; 1984 Jul; 25(7):737-42. PubMed ID: 6735255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.
    Garred P; Mollnes TE; Lea T
    Scand J Immunol; 1988 Mar; 27(3):329-35. PubMed ID: 2451274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.
    Elmgreen J; Berkowicz A; Sørensen H
    Acta Med Scand; 1983; 214(5):403-7. PubMed ID: 6660048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease.
    Patrone F; Dallegri F; Sacchetti C
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):322-3. PubMed ID: 696210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.
    Brandt E; Müller-Alouf H; Desreumaux P; Woerly G; Colombel JF; Capron M
    Eur Cytokine Netw; 1998 Dec; 9(4):647-53. PubMed ID: 9889409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune system activity in inflammatory bowel disease.
    Teisberg P; Gjone E
    Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors.
    Repo H; Leirisalo M; Kosunen TU
    J Immunol Methods; 1981; 46(2):227-42. PubMed ID: 7310132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease.
    Laufer J; Oren R; Goldberg I; Horwitz A; Kopolovic J; Chowers Y; Passwell JH
    Clin Exp Immunol; 2000 Apr; 120(1):30-7. PubMed ID: 10759760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.